The GM2 Activator Protein, a Novel Inhibitor of Platelet-Activating Factor

By Rigat B.   Reynaud D.   Smiljanic-Georgijev N.   Mahuran D.  

Biochemical and Biophysical Research Communications, Vol. 258, Iss. 2, 1999-05 ,pp. : 256-259

Elsevier

Access to resources Recommend Favorite

A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates

By Tropak Michael B   Bukovac Scott W   Rigat Brigitte A   Yonekawa Sayuri   Wakarchuk Warren   Mahuran Don J  

Glycobiology, Vol. 20, Iss. 3, 2010-03 ,pp. : 356-365

Oxford University Press

Access to resources Recommend Favorite

A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease

By Gratz Andreas   Götz Claudia   Jose Joachim  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 2, 2010-04 ,pp. : 234-239

Informa Healthcare

Access to resources Recommend Favorite

The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding

By Li J.  

Glycobiology, Vol. 11, Iss. 3, 2001-03 ,pp. : 217-229

Oxford University Press

Access to resources Recommend Favorite

Reevaluating the effect of Brefeldin A (BFA) on ganglioside synthesis: the location of GM2 synthase cannot be deduced from the inhibition of GM2 synthesis by BFA

By Young Jr- W.W.   Allende M.L.   Jaskiewicz E.  

Glycobiology, Vol. 9, Iss. 7, 1999-07 ,pp. : 689-695

Oxford University Press

Access to resources Recommend Favorite